Literature DB >> 24929113

Morphofunctional characterization of decellularized vena cava as tissue engineering scaffolds.

Matheus Bertanha1, Andrei Moroz2, Rodrigo G Jaldin3, Regina A M Silva4, Jaqueline C Rinaldi5, Márjorie A Golim6, Sérgio L Felisbino5, Maria A C Domingues7, Marcone L Sobreira3, Patricia P Reis3, Elenice Deffune8.   

Abstract

Clinical experience for peripheral arterial disease treatment shows poor results when synthetic grafts are used to approach infrapopliteal arterial segments. However, tissue engineering may be an option to yield surrogate biocompatible neovessels. Thus, biological decellularized scaffolds could provide natural tissue architecture to use in tissue engineering, when the absence of ideal autologous veins reduces surgical options. The goal of this study was to evaluate different chemical induced decellularization protocols of the inferior vena cava of rabbits. They were decellularized with Triton X100 (TX100), sodium dodecyl sulfate (SDS) or sodium deoxycholate (DS). Afterwards, we assessed the remaining extracellular matrix (ECM) integrity, residual toxicity and the biomechanical resistance of the scaffolds. Our results showed that TX100 was not effective to remove the cells, while protocols using SDS 1% for 2h and DS 2% for 1h, efficiently removed the cells and were better characterized. These scaffolds preserved the original organization of ECM. In addition, the residual toxicity assessment did not reveal statistically significant changes while decellularized scaffolds retained the equivalent biomechanical properties when compared with the control. Our results concluded that protocols using SDS and DS were effective at obtaining decellularized scaffolds, which may be useful for blood vessel tissue engineering.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Biomechanics; Blood vessels; Extracellular matrix; Peripheral arterial disease; Tissue engineering

Mesh:

Substances:

Year:  2014        PMID: 24929113     DOI: 10.1016/j.yexcr.2014.05.023

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Antigen removal process preserves function of small diameter venous valved conduits, whereas SDS-decellularization results in significant valvular insufficiency.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2020-03-07       Impact factor: 8.947

2.  Systematic in vitro comparison of decellularization protocols for blood vessels.

Authors:  Robin Simsa; Arvind Manikantan Padma; Philipp Heher; Mats Hellström; Andreas Teuschl; Lachmi Jenndahl; Niklas Bergh; Per Fogelstrand
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

3.  Acute aortic wall injury caused by aortic cross-clamping: morphological and biomechanical study of the aorta in a swine model of three aortic surgery approaches.

Authors:  Marcela Polachini Prata; Rodrigo Gibin Jaldin; Pedro Luiz Toledo de Arruda Lourenção; Marcone Lima Sobreira; Ricardo de Alvarenga Yoshida; Simone Antunes Terra; Rosa Marlene Viero; Winston Bonetti Yoshida
Journal:  J Vasc Bras       Date:  2020-03-12

Review 4.  Decellularized blood vessel development: Current state-of-the-art and future directions.

Authors:  Xinyu Wang; Vincent Chan; Peter R Corridon
Journal:  Front Bioeng Biotechnol       Date:  2022-08-08

5.  Tissue engineered bovine saphenous vein extracellular matrix scaffolds produced via antigen removal achieve high in vivo patency rates.

Authors:  Manuela Lopera Higuita; Juan F Lopera Giraldo; Tiffany L Sarrafian; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2021-06-27       Impact factor: 10.633

6. 

Authors:  Matheus Bertanha
Journal:  J Vasc Bras       Date:  2016 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.